Literature DB >> 12891938

[Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis].

E Gallego1, A López, I Lorenzo, E López, F Llamas, M L Illescas, E Andrés, A Serrano, E Olivas, C Gómez Roldán.   

Abstract

OBJECTIVE: We studied the influence of early vs late referral to nephrologist of patients with chronic renal failure over clinical situation at the onset of hemodialysis and outcome. SUBJECTS AND METHODS: From january 1994 to december 1998, 139 patients started hemodialysis for end-stage renal disease at the Hospital General de Albacete, all of them included in the study and clinical follow-up concluded in december 2001. Patients with rapidly progressive glomerulonephritis were excluded. Early (ER) and late referral (LR) were defined by the time of first nephrology encounter greater than or less than 6 months respectively, before iniciation of hemodialysis.
RESULTS: 106 patients (76.25%) were referred early; mean follow-up time 6.3 +/- 4.5 years. 33 patients (23.74%) had late referral, follow-up time was less then six months, 18 patients were followed during less than 4 weeks. There were no differences in demographic data and comorbid conditions between LR and ER patients (age, cardiac and vascular disease, diabetes, neoplasia...). Mean plasma concentration of creatinine and urea was significantly greater, whereas hematocrit and albumin were less in the LRA than the ER group. Emergency dialysis through central vein catheterisation was more frequent in the LR group. Number of admissions and duration of hospital stay were higher in the LR group. No significant differences in nutrition, dialysis doses or anemia were found between the two groups after 6 and 12 months of hemodialysis. Long term outcome was similar in both groups: no significant differences were found in percentage of patients transplanted or deceased after 3 years of treatment. Survival analysis failed to show a difference between ER and LR groups (mean survival time was 73.6 +/- 4.3 months and 73.0 +/- 6 months respectively).
CONCLUSION: Late referral to the nephrologist is associated with increased early morbidity vs early referral, although long term outcome is not worse if predialysis comorbid conditions are comparable and dialysis care achieve equal results in dialysis doses, nutrition and anemia in both groups in the first months of treatment. Improvement of outcome of patients referred early to the nephrologist will depend on the adoption of preventive measures over comorbidity factors that should be applied in early stages of renal disease.

Entities:  

Mesh:

Year:  2003        PMID: 12891938

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  6 in total

1.  Cost-effectiveness analysis of the Spanish renal replacement therapy program.

Authors:  Guillermo Villa; Lucía Fernández-Ortiz; Jesús Cuervo; Pablo Rebollo; Rafael Selgas; Teresa González; Javier Arrieta
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

2.  The organization and financing of end-stage renal disease in Spain.

Authors:  José Luño
Journal:  Int J Health Care Finance Econ       Date:  2007-12

3.  Outcomes of predialysis nephrology care in elderly patients beginning to undergo dialysis.

Authors:  Seon Ha Baek; Shin young Ahn; Sung Woo Lee; Youn Su Park; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Suhnggwon Kim; Ho Jun Chin
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions.

Authors:  Gernot Baer; Norbert Lameire; Wim Van Biesen
Journal:  NDT Plus       Date:  2009-04-29

5.  Effects of Early Frequent Nephrology Care on Emergency Department Visits among Patients with End-stage Renal Disease.

Authors:  Yun-Yi Chen; Likwang Chen; Jenq-Wen Huang; Ju-Yeh Yang
Journal:  Int J Environ Res Public Health       Date:  2019-03-31       Impact factor: 3.390

6.  Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial.

Authors:  Patrick Saudan; Belen Ponte; Nicola Marangon; Chantal Martinez; Lena Berchtold; David Jaques; Thomas Ernandez; Sophie de Seigneux; Sebastian Carballo; Thomas Perneger; Pierre-Yves Martin
Journal:  BMC Nephrol       Date:  2020-04-09       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.